Literature DB >> 6207262

Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors.

K L Rock, B Benacerraf, A K Abbas.   

Abstract

The present study examines the ability of hapten-specific murine splenic B lymphocytes to present hapten-proteins to carrier-specific T cell hybridomas. BALB/cB cells specific for 2,4,6-trinitrophenyl (TNP) were isolated from spleens of immune mice by elution from TNP-gelatin-coated dishes. Such cells presented the TNP-modified terpolymer, GL phi, at concentrations as low as 0.1 microgram/ml, to a GL phi-specific, I-Ed-restricted, interleukin 2-producing T cell hybridoma. In contrast, the same B lymphocytes required 1,000-fold higher concentrations of unmodified GL phi to stimulate the same T cell hybridoma. The presentation of low concentrations of TNP-GL phi by TNP-specific B lymphocytes was significantly or completely blocked by anti-Ig antibody or TNP-proteins, indicating that surface Ig receptors were critically involved in this phenomenon. Finally, binding of TNP-proteins did not alter the ability of the B cells to present unrelated, unhaptenated proteins or to stimulate alloreactive T cells. These results suggest that surface Ig receptors serve to focus antigens onto specific B lymphocytes and that such cells are highly efficient at presenting linked antigenic determinants to T cells. The implications of these findings for the mechanisms of physiologic, histocompatibility-restricted T-B collaboration are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207262      PMCID: PMC2187484          DOI: 10.1084/jem.160.4.1102

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  The function and interrelationships of T-cell receptors, Ir genes and other histocompatibility gene products.

Authors:  D H Katz; B Benacerraf
Journal:  Transplant Rev       Date:  1975

2.  The fate of anti-Ig-surface Ig complexes on B lymphocytes.

Authors:  H D Engers; E R Unanue
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

3.  Studies on the capacity of B cells to serve as antigen-presenting cells.

Authors:  R W Chesnut; H M Grey
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

4.  Accessory cell requirement in the proliferative response of T lymphocytes to hemocyanin.

Authors:  G M Kammer; E R Unanue
Journal:  Clin Immunol Immunopathol       Date:  1980-03

5.  Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin.

Authors:  J J Mond; E Seghal; J Kung; F D Finkelman
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

6.  The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization.

Authors:  D C Shreffler; C S David
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

7.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

8.  The role of H-2 linked genes in helper T-cell function. II. Isolation on antigen-pulsed macrophages of two separate populations of F1 helper T cells each specific for antigen and one set of parental H-2 products.

Authors:  J E Swierkosz; K Rock; P Marrack; J W Kappler
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

9.  Separation of antigen-specific lymphocytes. I. Enrichment of antigen-binding cells.

Authors:  W Haas; J E Layton
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  116 in total

1.  Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial.

Authors:  R T Naismith; L Piccio; J A Lyons; J Lauber; N T Tutlam; B J Parks; K Trinkaus; S K Song; A H Cross
Journal:  Neurology       Date:  2010-06-08       Impact factor: 9.910

2.  Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation.

Authors:  Caroline L Wilson; Dominic W Hine; Ariel Pradipta; Jeffrey P Pearson; Willem van Eden; John H Robinson; Andrew M Knight
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

3.  Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells.

Authors:  J P Scheerlinck; G Burssens; L Brys; A Michel; P Hauser; P De Baetselier
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

Review 4.  The cytoskeleton coordinates the early events of B-cell activation.

Authors:  Naomi E Harwood; Facundo D Batista
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

Review 5.  Cellular mechanisms of antigen processing and the function of class I and II major histocompatibility complex molecules.

Authors:  C V Harding; E R Unanue
Journal:  Cell Regul       Date:  1990-06

6.  Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter.

Authors:  Gabriel D Victora; Tanja A Schwickert; David R Fooksman; Alice O Kamphorst; Michael Meyer-Hermann; Michael L Dustin; Michel C Nussenzweig
Journal:  Cell       Date:  2010-11-12       Impact factor: 41.582

Review 7.  Membrane Ig-mediated triggering of B cell tolerance and B cell clonal expansion: implications for rheumatoid factor production in rheumatoid synovitis.

Authors:  P K Mongini; S M Rudich
Journal:  Springer Semin Immunopathol       Date:  1989

Review 8.  The ins and outs of MHC class II-mediated antigen processing and presentation.

Authors:  Paul A Roche; Kazuyuki Furuta
Journal:  Nat Rev Immunol       Date:  2015-02-27       Impact factor: 53.106

9.  Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo.

Authors:  P A Scherle; W Gerhard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  Factors influencing the immunogenicity of the haptenic drug chlorhexidine in mice. II. The role of the carrier and adjuvants in the induction of IgE and IgG anti-hapten responses.

Authors:  G T Layton; D R Stanworth; H E Amos
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.